Publication | Closed Access

Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis

Acute Lung InjuryPulmonary CareAllergyInflammatory Lung DiseaseLung InflammationChronic BronchitisRespiratory Infection7-Day Co-amoxiclav TherapyPulmonary MedicineFive-day Moxifloxacin TherapyMedicine